GTHX - G1 Therapeutics slips after new breast cancer data for lead asset
2024-05-28 14:34:16 ET
More on G1 Therapeutics
- G1 Therapeutics, Inc. (GTHX) Q1 2024 Earnings Call Transcript
- Why G1 Therapeutics Is A Speculative 'Buy' In The Oncology Biotech Landscape
- G1 Therapeutics, Inc. (GTHX) Q4 2023 Earnings Call Transcript
- G1 Therapeutics jumps amid takeover speculation (update)
- G1 Therapeutics and Pepper Bio sign license agreement for lerociclib